Last updated: 4 months ago
Oculis Holding AG's Phase 2 Trial Success: OCS-05 for Acute Optic Neuritis
Oculis Holding AG reports strong cash position and promising Phase 2 ACUITY trial results for OCS-05, indicating potential market opportunities in treating acute optic neuritis.